Listeria-based vaccines utilize a modified form of the bacterium Listeria monocytogenes, a pathogen known for causing foodborne illness. By genetically engineering this bacterium, scientists have been able to create vaccines that can potentially target and kill cancer cells. These vaccines work by exploiting Listeria's ability to stimulate a robust immune response, which can be redirected to attack tumor cells.
